Evidence map›Paper›PMID 35155837›Full record

ArticleBiochemistry and biophysics reports2022

Inhibitory effects of superoxide dismutase 3 on IgE production in B cells.

Gaurav Agrahari, Shyam Kishor Sah, Min Jung Lee, Chul Hwan Bang, Yeong Ho Kim, Hey-Young Kim, Tae-Yoon Kim

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gaurav AgrahariLaboratory of Dermato-Immunology, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.
Shyam Kishor SahDepartment of Reconstructive Sciences, Center for Regenerative Medicine and Skeletal Development, UConn Health, USA.
Min Jung LeeLaboratory of Dermato-Immunology, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.
Chul Hwan BangLaboratory of Dermato-Immunology, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.
Yeong Ho KimLaboratory of Dermato-Immunology, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.
Hey-Young KimLaboratory of Dermato-Immunology, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.
Tae-Yoon KimLaboratory of Dermato-Immunology, College of Medicine, The Catholic University of Korea, 06591, Seoul, Republic of Korea.
Catholic University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin E (IgE) functions as a first-line defense against parasitic infections. However, aberrant production of IgE is known to be associated with various life-threatening allergic diseases. Superoxide dismutase 3 (SOD3) has been found to suppress IgE in various allergic diseases such as allergic conjunctivitis, ovalbumin-induced allergic asthma, and dust mite-induced atopic dermatitis-like skin inflammation. However, the role of SOD3 in the regulation of IgE production in B cells remains elusive. In this study, we investigated the effect of SOD3 on LPS/IL-4 and anti-CD40/IL-4-mediated secretion of IgE in murine B cells. Our data showed that SOD3 can suppress both LPS/IL-4 and antiCD40/IL-7-induced IgE secretion in B cells isolated from both wild-type (

Indexed as

B cellsClass switch recombinationImmunoglobulin ESignaling pathwaysSuperoxide dismutase 3

Identifiers

PMID35155837
PMCPMC8822298
OpenAlexW4210389697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.